← Back to headlines
Definium Therapeutics Stock Poised for Gains After Positive Emerge Trial Update
Definium Therapeutics, Inc. (DFTX) stock is being evaluated for further gains following a positive update from its Emerge trial.
30 Jun, 13:21 — 30 Jun, 13:21
Sources
Showing 1 of 1 sources
